Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

How I treat priapism.

Anele UA, Le BV, Resar LM, Burnett AL.

Blood. 2015 Jun 4;125(23):3551-8. doi: 10.1182/blood-2014-09-551887. Epub 2015 Mar 25.

2.

Insights of priapism mechanism and rationale treatment for recurrent priapism.

Yuan J, Desouza R, Westney OL, Wang R.

Asian J Androl. 2008 Jan;10(1):88-101. Review.

3.

Medical management of ischemic stuttering priapism: a contemporary review of the literature.

Levey HR, Kutlu O, Bivalacqua TJ.

Asian J Androl. 2012 Jan;14(1):156-63. doi: 10.1038/aja.2011.114. Epub 2011 Nov 7. Review.

4.

Molecular pathophysiology of priapism: emerging targets.

Anele UA, Morrison BF, Burnett AL.

Curr Drug Targets. 2015;16(5):474-83. Review.

5.

Erectile dysfunction after sickle cell disease-associated recurrent ischemic priapism: profile and risk factors.

Anele UA, Burnett AL.

J Sex Med. 2015 Mar;12(3):713-9. doi: 10.1111/jsm.12816. Epub 2015 Jan 9.

6.

Priapism and sickle-cell anemia: diagnosis and nonsurgical therapy.

Broderick GA.

J Sex Med. 2012 Jan;9(1):88-103. doi: 10.1111/j.1743-6109.2011.02317.x. Epub 2011 Jun 23. Review.

PMID:
21699659
7.

Establishment of a transgenic sickle-cell mouse model to study the pathophysiology of priapism.

Bivalacqua TJ, Musicki B, Hsu LL, Gladwin MT, Burnett AL, Champion HC.

J Sex Med. 2009 Sep;6(9):2494-504. doi: 10.1111/j.1743-6109.2009.01359.x. Epub 2009 Jun 11.

8.

Stuttering priapism: insights into pathogenesis and management.

Morrison BF, Burnett AL.

Curr Urol Rep. 2012 Aug;13(4):268-76. doi: 10.1007/s11934-012-0258-9. Review.

PMID:
22648304
9.

Increased cavernosal relaxations in sickle cell mice priapism are associated with alterations in the NO-cGMP signaling pathway.

Claudino MA, Franco-Penteado CF, Corat MA, Gimenes AP, Passos LA, Antunes E, Costa FF.

J Sex Med. 2009 Aug;6(8):2187-96. doi: 10.1111/j.1743-6109.2009.01337.x. Epub 2009 Jun 2.

PMID:
19493282
10.

Penile Doppler ultrasound in men with stuttering priapism and sickle cell disease -- a labile baseline diastolic velocity is a characteristic finding.

Patel U, Sujenthiran A, Watkin N.

J Sex Med. 2015 Feb;12(2):549-56. doi: 10.1111/jsm.12756. Epub 2014 Nov 26.

PMID:
25424427
11.

Molecular analysis of erection regulatory factors in sickle cell disease associated priapism in the human penis.

Lagoda G, Sezen SF, Cabrini MR, Musicki B, Burnett AL.

J Urol. 2013 Feb;189(2):762-8. doi: 10.1016/j.juro.2012.08.198. Epub 2012 Oct 8.

12.

Adenosine signaling, priapism and novel therapies.

Dai Y, Zhang Y, Phatarpekar P, Mi T, Zhang H, Blackburn MR, Xia Y.

J Sex Med. 2009 Mar;6 Suppl 3:292-301. doi: 10.1111/j.1743-6109.2008.01187.x. Review.

PMID:
19267852
13.

Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism.

Burnett AL, Bivalacqua TJ, Champion HC, Musicki B.

Urology. 2006 May;67(5):1043-8.

PMID:
16698365
14.

High flow priapism associated with sickle cell disease.

Ramos CE, Park JS, Ritchey ML, Benson GS.

J Urol. 1995 May;153(5):1619-21.

PMID:
7714988
15.

New insights into the pathophysiology of sickle cell disease-associated priapism.

Bivalacqua TJ, Musicki B, Kutlu O, Burnett AL.

J Sex Med. 2012 Jan;9(1):79-87. doi: 10.1111/j.1743-6109.2011.02288.x. Epub 2011 May 6. Review.

PMID:
21554553
16.

Valsalva maneuver-induced priapism: a hidden culprit.

Chen WL, Tsai WC, Tsao YT.

J Sex Med. 2009 Apr;6(4):1181-1184. doi: 10.1111/j.1743-6109.2008.01175.x. Epub 2008 Feb 4.

PMID:
19207269
17.

Hydroxyurea therapy for priapism prevention and erectile function recovery in sickle cell disease: a case report and review of the literature.

Anele UA, Mack AK, Resar LMS, Burnett AL.

Int Urol Nephrol. 2014 Sep;46(9):1733-1736. doi: 10.1007/s11255-014-0737-7. Epub 2014 May 14. Review.

18.

Priapism pathophysiology: clues to prevention.

Burnett AL.

Int J Impot Res. 2003 Oct;15 Suppl 5:S80-5. Review.

PMID:
14551582
19.

Priapism in boys. Management with cavernosaphenous shunt.

Resnick MI, Holland JM, King LR, Grayhack JT.

Urology. 1975 Apr;5(4):492-5.

PMID:
1129866
20.

Sildenafil citrate-restored eNOS and PDE5 regulation in sickle cell mouse penis prevents priapism via control of oxidative/nitrosative stress.

Bivalacqua TJ, Musicki B, Hsu LL, Berkowitz DE, Champion HC, Burnett AL.

PLoS One. 2013 Jul 2;8(7):e68028. doi: 10.1371/journal.pone.0068028. Print 2013.

Supplemental Content

Support Center